A new study published in the Annals of Internal Medicine shows that clinical trials funded by the pharmaceutical industry are more likely to result in positive outcomes when compared to those funded by the government or non-profit/non-federal sources. The study also indicates those same trials are less likely to be published.
The study compared 546 clinical drug trials that were registered on clinicaltrials.gov. Of those, 346 were funded by the industry, 74 by government sources, and 126 by non-profit or non-federal organizations.
Out of the industry funded trials that were published 84.5% of them reported positive outcomes, as opposed to 50% by the government and 32.4% of the non-profit or non-federal publishings.